Type 2 diabetes and stem cell claims

Category: Conditions & evidence · Editorial Review: Updated 20 October 2026 · 3 minute read

Type 2 diabetes is complex

Type 2 diabetes involves insulin resistance and changing insulin-producing capacity, with considerable variation between people. It is not simply a shortage of a single cell population that any infusion can correct. A treatment proposal should account for your glucose control, cardiovascular and kidney health, medicines and overall goals.

Do not extrapolate from other diabetes research

A report about islet replacement in selected people with type 1 diabetes does not prove benefit for type 2 diabetes. Nor does a laboratory finding establish that a commercially offered product improves outcomes. Ask for clinical evidence in people with type 2 diabetes receiving the exact product and route proposed to you.

Look for durable outcomes

Short-term glucose changes can reflect diet, medication adjustment, illness or altered activity during travel. Ask whether research measured sustained glucose control, medication use, severe adverse effects and relevant health outcomes. A normal reading shortly after a procedure is not proof of disease reversal.

Use an endocrinology review

Bring recent glucose records, HbA1c results and a complete medicine list. Ask how the proposed intervention compares with established diabetes care and whether it might disrupt treatments that protect your heart or kidneys. Agree on medication changes only with the responsible clinician, and ensure that follow-up continues after returning home.

Continue exploring

• Acute myeloid leukemia and transplantation
• Acute lymphoblastic leukemia and transplantation
• Multiple myeloma and autologous transplant
• Prepare your consultation checklist

Sources & further reading

• Primary patient information and research

Read alongside your treating specialist’s advice. Clinical eligibility, exact products and treatment plans require individual assessment.